AU1222501A - Identification of arsacs mutations and methods of use therefor - Google Patents
Identification of arsacs mutations and methods of use thereforInfo
- Publication number
- AU1222501A AU1222501A AU12225/01A AU1222501A AU1222501A AU 1222501 A AU1222501 A AU 1222501A AU 12225/01 A AU12225/01 A AU 12225/01A AU 1222501 A AU1222501 A AU 1222501A AU 1222501 A AU1222501 A AU 1222501A
- Authority
- AU
- Australia
- Prior art keywords
- arsacs
- mutations
- identification
- methods
- use therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16058899P | 1999-10-20 | 1999-10-20 | |
US60160588 | 1999-10-20 | ||
PCT/US2000/029130 WO2001029266A2 (en) | 1999-10-20 | 2000-10-20 | Identification of arsacs mutations and methods of use therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1222501A true AU1222501A (en) | 2001-04-30 |
Family
ID=22577507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU12225/01A Abandoned AU1222501A (en) | 1999-10-20 | 2000-10-20 | Identification of arsacs mutations and methods of use therefor |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1222501A (en) |
WO (1) | WO2001029266A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117820470A (en) * | 2024-03-04 | 2024-04-05 | 暨南大学 | Humanized recombinant anti-Spastin antibody and preparation method and application thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150091A (en) * | 1996-03-06 | 2000-11-21 | Baylor College Of Medicine | Direct molecular diagnosis of Friedreich ataxia |
-
2000
- 2000-10-20 WO PCT/US2000/029130 patent/WO2001029266A2/en active Application Filing
- 2000-10-20 AU AU12225/01A patent/AU1222501A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001029266A2 (en) | 2001-04-26 |
WO2001029266A3 (en) | 2002-07-11 |
WO2001029266A9 (en) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU6117000A (en) | Novel polynucleotides and method of use thereof | |
AU6915400A (en) | System of reusable software parts and methods of use | |
AU2468401A (en) | Underreamer and method of use | |
AU2002314466A1 (en) | Withasol and methods of use | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
EP1183030A4 (en) | Methods of making and using n-desmethylzopiclone | |
AU3622600A (en) | Metalloproteinases and methods of use therefor | |
AU715620C (en) | Therapeutic methods and uses | |
AU5116100A (en) | Connector and method of use of the connector | |
AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
AU1083501A (en) | Antibiotic-metal complex and methods | |
AU3501700A (en) | Human endokine alpha and methods of use | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
GB2356703B (en) | Method and kit for evaluation of HIV mutations | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU1894601A (en) | Novel gene and use thereof | |
AU1222501A (en) | Identification of arsacs mutations and methods of use therefor | |
AU3725500A (en) | Hand-held bidet and method of use | |
AU2669201A (en) | Taccalonolides and their use | |
AU5634400A (en) | Shank proteins and methods of use thereof | |
AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof | |
AU3863900A (en) | Prolyl peptidases and methods of use | |
AU2567599A (en) | Anti-ccr1 antibodies and methods of use therefor | |
AU3793701A (en) | Methods of identifying optimal drug combinations and compositions thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |